Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126459502 | 12645950 | 2 | F | 20150116 | 20160811 | 20160815 | PER | US-PFIZER INC-2015024134 | PFIZER | 0.00 | F | Y | 0.00000 | 20160815 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126459502 | 12645950 | 1 | SS | THEOPHYLLINE | THEOPHYLLINE ANHYDROUS | 1 | UNK | U | 0 | TABLET | |||||||||
| 126459502 | 12645950 | 2 | SS | ACETAZOLAMIDE. | ACETAZOLAMIDE | 1 | UNK | U | 0 | ||||||||||
| 126459502 | 12645950 | 3 | PS | ERYTHROMYCIN. | ERYTHROMYCIN | 1 | UNK | U | 50609 | ||||||||||
| 126459502 | 12645950 | 4 | SS | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | UNK | U | 0 | ||||||||||
| 126459502 | 12645950 | 5 | SS | THEO-DUR | THEOPHYLLINE ANHYDROUS | 1 | UNK | U | 0 | ||||||||||
| 126459502 | 12645950 | 6 | SS | CYCLOSPORINE. | CYCLOSPORINE | 1 | UNK | U | 0 | ||||||||||
| 126459502 | 12645950 | 7 | SS | TELITHROMYCIN | TELITHROMYCIN | 1 | UNK | U | 0 |
Indications of drugs used
| no results found |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126459502 | 12645950 | Asthma | |
| 126459502 | 12645950 | Drug hypersensitivity | |
| 126459502 | 12645950 | Dyspnoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |